CROs/Service Providers

MNX opens logistics facility in Amsterdam

Thursday, August 27, 2015

Irvine, Calif.-based MNX Global Logistics has opened a dedicated supply chain and logistics facility in Amsterdam, the Netherlands, just outside of Amsterdam Airport Schiphol. The facility, which has validated temperature-controlled supply chain capabilities, will serve as the operations and warehousing hub for the company’s life sciences and medical device customers throughout Europe.

[Read More]

Hepalink to acquire Cytovance

Wednesday, August 26, 2015

Hepalink USA, a China-based global supplier of heparin sodium API, has entered into a definitive agreement to acquire Cytovance Biologics, a biopharmaceutical contract development manufacturing (CDMO) company, for $205.68 million in cash plus certain contingent payments.

[Read More]

Medpace expands in the U.K.

Friday, August 14, 2015

Global CRO Medpace has relocated its existing U.K. office in Stirling, Scotland. The new office is roughly three times the size of the former facility, allowing for significant growth in data management, biostatistics, quality assurance, regulatory affairs, clinical operations and safety.

[Read More]

Verified Clinical Trials inks two partner agreements

Thursday, August 13, 2015

AXIS Clinicals USA, a Dilworth, Minn.-based CRO, has partnered with the Verified Clinical Trials (VCT) national clinical trial database registry to stop attempts at dual enrollment in clinical trial research, thus preventing protocol deviations, improving data quality and promoting subject safety. Within the first seven days of use, the VCT system proved its worth by stopping a subject’s attempt at dual enrollment. VCT is the largest North American database registry in both early and late phase clinical trials.

[Read More]

Accelovance to expand in Wales

Thursday, August 13, 2015

Accelovance, a Rockville, Md.-based CRO focused on oncology, vaccines and general medicine, is expanding its international presence with a new facility in Wales, which is expected to create 70 new clinical research jobs. The expansion will be financed by the Welsh government, enabling Accelovance to grow its global workforce over the next two years.

[Read More]